CR10673A - Derivado de 2-piridincarboxamida que tiene efecto activador de gk - Google Patents

Derivado de 2-piridincarboxamida que tiene efecto activador de gk

Info

Publication number
CR10673A
CR10673A CR10673A CR10673A CR10673A CR 10673 A CR10673 A CR 10673A CR 10673 A CR10673 A CR 10673A CR 10673 A CR10673 A CR 10673A CR 10673 A CR10673 A CR 10673A
Authority
CR
Costa Rica
Prior art keywords
pyridincarboxamide
derived
activating effect
activating
effect
Prior art date
Application number
CR10673A
Other languages
English (en)
Inventor
Noriaki Hashimoto
Yufu Sagara
Masanori Asai
Teruyuki Nishimura
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of CR10673A publication Critical patent/CR10673A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
CR10673A 2006-10-06 2009-03-19 Derivado de 2-piridincarboxamida que tiene efecto activador de gk CR10673A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006275824 2006-10-06

Publications (1)

Publication Number Publication Date
CR10673A true CR10673A (es) 2009-09-03

Family

ID=39282963

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10673A CR10673A (es) 2006-10-06 2009-03-19 Derivado de 2-piridincarboxamida que tiene efecto activador de gk

Country Status (22)

Country Link
US (1) US8338460B2 (es)
EP (1) EP2077266B1 (es)
JP (1) JP5292100B2 (es)
KR (1) KR20090060426A (es)
CN (1) CN101522673A (es)
AR (1) AR063028A1 (es)
AU (1) AU2007307560B2 (es)
BR (1) BRPI0716590A2 (es)
CA (1) CA2667068C (es)
CL (1) CL2007002890A1 (es)
CO (1) CO6180507A2 (es)
CR (1) CR10673A (es)
GT (1) GT200900065A (es)
IL (1) IL197714A0 (es)
MA (1) MA30813B1 (es)
MX (1) MX2009003073A (es)
NO (1) NO20091793L (es)
PE (1) PE20081195A1 (es)
RU (1) RU2009117209A (es)
SV (1) SV2009003196A (es)
TW (1) TW200831504A (es)
WO (1) WO2008044777A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004220234C1 (en) * 2003-02-13 2013-01-17 Msd K.K. Novel 2-pyridinecarboxamide derivatives
AR063028A1 (es) 2006-10-06 2008-12-23 Banyu Pharma Co Ltd Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen.
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US8232284B2 (en) 2007-11-12 2012-07-31 Msd K. K. Heteroaryloxy quinazoline derivative
WO2010018800A1 (en) 2008-08-15 2010-02-18 Banyu Pharmaceutical Co.,Ltd. Acetyl pyrrolidinyl indole derivative
AU2009285194A1 (en) * 2008-08-29 2010-03-04 Banyu Pharmaceutical Co.,Ltd. Oxotetrahydrofuran-2-yl-benzimidazole derivative
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2931718B1 (en) 2012-12-17 2019-01-16 Merck Sharp & Dohme Corp. Novel 2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment
CN113045546A (zh) * 2021-03-25 2021-06-29 浙江天宇药业股份有限公司 一种吡咯替尼杂质、其制备方法及用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3630200A (en) 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
GB2277930A (en) 1993-05-11 1994-11-16 Shell Int Research Herbicidal picolinamide derivatives
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
SE0102300D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
SE519859C2 (sv) 2001-08-17 2003-04-15 Novacast Ab Anordning för behandling av järnlegeringar i ett kärl
DE60328671D1 (de) * 2002-03-26 2009-09-17 Banyu Pharma Co Ltd Neue aminobenzamidderivate
AU2004220234C1 (en) 2003-02-13 2013-01-17 Msd K.K. Novel 2-pyridinecarboxamide derivatives
AU2004215514B2 (en) 2003-02-26 2010-03-04 Msd K.K. Heteroarylcarbamoylbenzene derivative
KR101204247B1 (ko) 2003-07-22 2012-11-22 아스텍스 테라퓨틱스 리미티드 3,4-이치환된 1h-피라졸 화합물 및 그의 시클린 의존성키나제 (cdk) 및 글리코겐 합성효소 키나제-3(gsk-3) 조정제로서 용도
US20050176767A1 (en) 2003-10-30 2005-08-11 Laval Chan Chun Kong Pyridine carboxamide and methods for inhibiting HIV integrase
US7435831B2 (en) 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
GB0412468D0 (en) 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds
KR100716891B1 (ko) 2005-11-01 2007-05-09 (주)아모레퍼시픽 피리딘 티아졸 카복사마이드 유도체, 이의 제조방법 및이를 함유하는 피부 미백용 조성물
US7951824B2 (en) 2006-02-17 2011-05-31 Hoffman-La Roche Inc. 4-aryl-pyridine-2-carboxyamide derivatives
EP1849785A1 (en) 2006-04-28 2007-10-31 Neuropharma, S.A. N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
AR063028A1 (es) 2006-10-06 2008-12-23 Banyu Pharma Co Ltd Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
RU2009117209A (ru) 2010-11-20
WO2008044777A1 (en) 2008-04-17
TW200831504A (en) 2008-08-01
GT200900065A (es) 2010-04-28
NO20091793L (no) 2009-05-05
KR20090060426A (ko) 2009-06-12
JPWO2008044777A1 (ja) 2010-02-18
CA2667068A1 (en) 2008-04-17
CO6180507A2 (es) 2010-07-19
MX2009003073A (es) 2009-04-02
CN101522673A (zh) 2009-09-02
CL2007002890A1 (es) 2008-01-18
US8338460B2 (en) 2012-12-25
AR063028A1 (es) 2008-12-23
AU2007307560A1 (en) 2008-04-17
PE20081195A1 (es) 2008-09-04
EP2077266A1 (en) 2009-07-08
JP5292100B2 (ja) 2013-09-18
IL197714A0 (en) 2009-12-24
CA2667068C (en) 2012-03-27
MA30813B1 (fr) 2009-10-01
EP2077266B1 (en) 2012-07-25
EP2077266A4 (en) 2010-07-07
US20080090799A1 (en) 2008-04-17
AU2007307560B2 (en) 2012-10-04
SV2009003196A (es) 2009-07-28
BRPI0716590A2 (pt) 2012-12-25

Similar Documents

Publication Publication Date Title
CR10673A (es) Derivado de 2-piridincarboxamida que tiene efecto activador de gk
CR10841A (es) Imidazotriazinas imidazopirimidinas inhibidores de cinasa
DE602007012130D1 (de) Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase
NO20073375L (no) Krydderflaske
DK2018201T3 (da) Forstøver
DE602007001471D1 (de) Motorsystem
FI20065065A0 (fi) Jauhin
DE602007001191D1 (de) Öl-in-öl-emulsionen
DE602007014135D1 (de) Befestigungsvorrichtung
FI20060795A (fi) Kylläisyyttä aiheuttava tuote
DE602006008892D1 (de) Kompaktes system zur verpackung von injizierbaren gungen
DE502006002959D1 (de) Schraubdeckel
DE602007009224D1 (de) R-cellular-systemen
FI20060070A0 (fi) Lukkomutteri
DE112007000111A5 (de) Schraubdeckel
BRPI0712951A2 (pt) Unidade de aplicação
FI20070610A0 (fi) Jauhinlevy
DE502007005650D1 (de) Handbremseinrichtung
DE502007003458D1 (de) Brennkraftmaschinensystem
ES1062814Y (es) Jamonero
ES1062475Y (es) Jamonero
DE502007006013D1 (de) Handbremseinrichtung
DE602007012006D1 (de) htung
FI20065032A0 (fi) Menetelmä asbestialtistumiseen liittyvien keuhkosyöpien tunnistamiseksi
ITCA20060014A1 (it) Raviolo di pompia o arrabiorheddu de pompia